Halozyme Therapeutics HALO Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's other intangible assets—net?
- Halozyme Therapeutics (HALO) reported other intangible assets—net of $951.96M in Q1 2026.
- How has Halozyme Therapeutics's other intangible assets—net changed year-over-year?
- Halozyme Therapeutics's other intangible assets—net increased by 147.9% year-over-year, from $384.07M to $951.96M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.